Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.
about
Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting the PTTG1 oncogene i ...... the BRAF inhibitor dabrafenib.
@en
Targeting the PTTG1 oncogene i ...... the BRAF inhibitor dabrafenib.
@nl
type
label
Targeting the PTTG1 oncogene i ...... the BRAF inhibitor dabrafenib.
@en
Targeting the PTTG1 oncogene i ...... the BRAF inhibitor dabrafenib.
@nl
prefLabel
Targeting the PTTG1 oncogene i ...... the BRAF inhibitor dabrafenib.
@en
Targeting the PTTG1 oncogene i ...... the BRAF inhibitor dabrafenib.
@nl
P2093
P2860
P356
P1433
P1476
Targeting the PTTG1 oncogene i ...... the BRAF inhibitor dabrafenib
@en
P2093
Alessandro Scoppola
Ester Alvino
Federica Ruffini
Gian Carlo Antonini Cappellini
Laura Bonmassar
Lauretta Levati
Simona Caporali
Simona Mastroeni
Stefania D'Atri
P2860
P304
113472-113493
P356
10.18632/ONCOTARGET.23052
P407
P577
2017-12-09T00:00:00Z